United States · FDA National Drug Code directory

Loratadine Allergy Relief

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 76420-330_359e8af9-0b81-5837-e063-6394a90a58a1
Product NDC: 76420-330
Form: TABLET
Composition / generic term: Loratadine
Labeler: Asclemed USA, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20171101
Source listing expiry: 20261231

Source-listed ingredients

LORATADINE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET in 1 BOTTLE (76420-330-01) · 76420-330-01
300 TABLET in 1 BOTTLE (76420-330-03) · 76420-330-03
500 TABLET in 1 BOTTLE (76420-330-05) · 76420-330-05
10 TABLET in 1 BOTTLE (76420-330-10) · 76420-330-10
10 TABLET in 1 BLISTER PACK (76420-330-11) · 76420-330-11
20 TABLET in 1 BOTTLE (76420-330-20) · 76420-330-20
30 TABLET in 1 BOTTLE (76420-330-30) · 76420-330-30
30 TABLET in 1 BLISTER PACK (76420-330-31) · 76420-330-31
60 TABLET in 1 BOTTLE (76420-330-60) · 76420-330-60
90 TABLET in 1 BOTTLE (76420-330-90) · 76420-330-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →